<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=windows-1250">
<TITLE>Medical Data description:</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF">
<IMG SRC="razitko.gif" WIDTH=170 HEIGHT=162 ALIGN="LEFT" HSPACE=9
VSPACE=-10>

<p>&nbsp;&nbsp;</p>
<H1>PKDD'99 Discovery Challenge</H1>
<H1>Guide to the Medical Data Set</H1>

<p>&nbsp;&nbsp;&nbsp;</p>
<H2>Domain</H2>

<p>Databases are collected at the University hospital. Each patient 
came to the outpatient clinic on collagen diseases, who is introduced
by some home doctors or general physicians in the local hospitals.</p>

<p>Collagen diseases are auto-immune diseases whose patients generate
antibodies attacking to their bodies. For example, if a patient generates
antibodies to lung, he/she will lose the respiratory function in a
chronic course and finally lose their lives. The disease mechanisms are only
partially known and their classification are still fuzzy. Some patients
may generate many kinds of antibodies and their manifestations may
include all the characteristics of collagen diseases.</p>
<p>&nbsp;</p>

<p>In these diseases, thrombosis is one of the most important and severe
complications, one of the major cause of death in collagen diseases.
Recently, this complication is closely related with anti-cardiolipin
antibodies, which was discovered by the medical physicians, one of
whom donated the datasets for discovery challenge.</P>

<p>Thrombosis is emergency and
it is important to detect and predict the possibilities of thrombosis.
However, such database analysis has not been made by any experts on
immunology.
Domain experts are very much interested in discovering some regularities
behind patients' observations, which may be a really new discovery in
the world.</P>

&nbsp;
<H2>Goal</H2>

<OL>
<LI>Search for good patterns which detect and predict thrombosis.</LI>
<LI>Search for temporal patterns specific/sensitive to thrombosis.
   (Examination date is very close to the date on thrombosis.
    If we can find specific/sensitive patterns before/after the
    thrombosis, they are very useful.)
<LI>Search for good features which classifies collagen diseases correctly.
<LI>Search for temporal patterns specific/sensitive to each collagen diseases.
</OL>

<p>Domain experts told us that if useful patterns are discovered 
then they are acceptable in major journals on rheumatology(collagen
diseases.)</p>

&nbsp;
<H2>Evaluation Scheme</H2>

<p>One of the domain experts, who is well known for rheumatology, 
will attend PKDD'99 conference and evaluate all the results.
The results will be also evaluated in the clinical environment in the
future.</p>

&nbsp;
<H2>Databases</H2>

<p>Databases consists of three tables. 
(tsumoto_a.csv, tsumoto_b.csv, tsumoto_c.csv).
The patients in these three tables are connected by ID number.</p>

<p>&nbsp;</p>
<H3>tsumoto_a.csv</H3>
<p>Basic Information about Patients (Input by Experts).
This dataset includes all patients.</p>

<TABLE CELLSPACING=0 BORDER CELLPADDING=4 WIDTH=85%>
<TR><TH>item</TH><TH>meaning</TH><TH>remark</TH></TR>
<TR><TD>ID</TD><TD>identification of the patient</TD><TD></TD></TR>
<TR><TD>Sex</TD><TD></TD><TD></TD></TR>
<TR><TD>Birthday</TD><TD></TD><TD>YYYY/M/D</TD></TR>
<TR><TD>Description date</TD><TD>the date when a patient was input</TD><TD></TD></TR>
<TR><TD>First date</TD><TD>the date when a patient came to the hospital</TD><TD></TD></TR>
<TR><TD>Admission</TD><TD>patient was admitted to the hospital or followed
at the outpatient clinic</TD><TD></TD></TR>
<TR><TD>Diagnosis</TD><TD>some patients may suffer from several
diseases</TD><TD>multivalued attribute</TD></TR>
</TABLE>

<p>&nbsp;</p>
<H3>tsumoto_b.csv</H3>
<p>Special Laboratory Examinations (Input by Experts)
   (Measured by the Laboratory on Collagen Diseases)This 
dataset does not include all the patients,
 but includes the patients with these special tests.</P>

<TABLE CELLSPACING=0 BORDER CELLPADDING=4 WIDTH=85%>
<TR><TH>item</TH><TH>meaning</TH><TH>remark</TH></TR>
<TR><TD>ID</TD><TD>identification of the patient</TD><TD></TD></TR>
<TR><TD>Examination Date</TD><TD>date of the test</TD><TD>YYYY/MM/DD</TD></TR>
<TR><TD>aCL IgG</TD><TD>anti-Cardiolipin antibody (IgG)<TD></TD></TR>
<TR><TD>aCL IgM</TD><TD>anti-Cardiolipin antibody (IgM)<TD></TD></TR>
<TR><TD>ANA</TD><TD>anti-nucleus antibody</TD><TD></TD></TR>
<TR><TD>ANA Pattern</TD><TD> pattern observed in the sheet of ANA
examination</TD><TD></TD></TR>
<TR><TD>aCL IgA</TD><TD>anti-Cardiolipin antibody (IgA)</TD><TD></TD></TR>
<TR><TD>Diagnosis</TD><TD></TD><TD>multivalued attribute</TD></TR>
<TR><TD>KCT</TD><TD>meassure of degree of coagulation</TD><TD></TD></TR>
<TR><TD>RVVT</TD><TD>meassure of degree of coagulation</TD><TD></TD></TR> 
<TR><TD>LAC</TD><TD>meassure of degree of coagulation</TD><TD></TD></TR>
<TR><TD>Symptoms</TD><TD>other symptoms observed in each patient</TD><TD></TD></TR>
<TR><TD>Thrombosis</TD><TD>degree of thrombosis (the Target)</TD>
<TD>0: negative <br> 1: positive <br> 2: positive and very severe</TD></TR>
</TABLE>
<br>
Examination date is very close to the date on thrombosis. In negative examples, these tests are 
examined when thrombosis is suspected.

<p>&nbsp;</p>
<H3>tsumoto_c.csv</H3>
<p> Laboratory Examinations stored in Hospital Information Systems
(Stored from 1980 to 1999.3) All the data includes ordinary laboratory examinations
and have temporal stamps.</p>


<TABLE CELLSPACING=0 BORDER CELLPADDING=4 WIDTH=85%>
<TR><TH>item</TH><TH>meaning</TH><TH>normal range</TH></TR>
<TR><TD>ID</TD><TD>identification of the patient</TD><TD></TD></TR>
<TR><TD>Date</TD><TD>Date of the laboratory tests (YYMMDD)</TD><TD></TD></TR>
<TR><TD>GOT</TD><TD>AST glutamic oxaloacetic transaminase</TD><TD>N < 60</TD></TR>
<TR><TD>GPT</TD><TD>ALT glutamic pylvic transaminase</TD><TD>N < 60</TD></TR>
<TR><TD>LDH</TD><TD>lactate dehydrogenase</TD><TD>N < 500</TD></TR>
<TR><TD>ALP</TD><TD>alkaliphophatase</TD><TD>N < 300</TD></TR>
<TR><TD>TP</TD><TD>total protein</TD><TD>6.0 < N < 8.5</TD></TR>
<TR><TD>ALB</TD><TD>albumin</TD><TD>3.5 < N < 5.5</TD></TR>
<TR><TD>UA</TD><TD>uric acid</TD><TD>N > 8.0 (Male) <br> N > 6.5 (Female)</TD></TR>
<TR><TD>UN</TD><TD>urea nitrogen</TD><TD>N > 30</TD></TR>
<TR><TD>CRE</TD><TD>creatinine</TD><TD>N > 1.5</TD></TR>
<TR><TD>T-BIL</TD><TD>total bilirubin</TD><TD>N < 2.0</TD></TR>
<TR><TD>T-CHO</TD><TD>total cholesterol</TD><TD>N < 250</TD></TR>
<TR><TD>TG</TD><TD>triglyceride</TD><TD>N < 200</TD></TR>
<TR><TD>CPK</TD><TD>creatinine phosphokinase</TD><TD>N < 250</TD></TR>
<TR><TD>GLU</TD><TD>blood glucose</TD><TD>N < 180</TD></TR>
<TR><TD>WBC</TD><TD>White blood cell</TD><TD>3500 < N < 9000</TD></TR>
<TR><TD>RBC</TD><TD>Red blood cell</TD><TD>350 < N < 600</TD></TR>
<TR><TD>HGB</TD><TD>Hemoglobin</TD><TD>10 < N < 17</TD></TR>
<TR><TD>HCT</TD><TD>Hematoclit</TD><TD>29 < N < 52</TD></TR>
<TR><TD>PLT</TD><TD>platelet</TD><TD>100 < N < 400</TD></TR>
<TR><TD>PT</TD><TD>prothrombin time</TD><TD>N < 14</TD></TR>
<TR><TD>APTT</TD><TD>activated partial prothrombin time</TD><TD>N < 45</TD></TR>
<TR><TD>FG</TD><TD>fibrinogen</TD><TD>150 < N < 450</TD></TR>
<TR><TD>PIC</TD><TD>plasmininhibitor-plasmin complex</TD><TD>N < 0.8</TD></TR>
<TR><TD>TAT</TD><TD>thrombin-antithrombin III complex</TD><TD>N < 3.0</TD></TR>
<TR><TD>U-PRO</TD><TD>proteinuria</TD><TD>0 < N 30</TD></TR>
<TR><TD>IGG</TD><TD>Ig G</TD><TD>900 < N < 2000</TD></TR>
<TR><TD>IGA</TD><TD>Ig A</TD><TD>80 < N < 500</TD></TR>
<TR><TD>IGM</TD><TD>Ig M</TD><TD>40 < N < 400</TD></TR>
<TR><TD>CRP</TD><TD>C-reactive protein</TD><TD>N= -, +-,   or  N < 1.0</TD></TR>
<TR><TD>RA</TD><TD>Rhuematoid Factor</TD><TD>N= -, +-</TD></TR>
<TR><TD>RF</TD><TD>RAHA</TD><TD>N < 20</TD></TR>
<TR><TD>C3</TD><TD>complement 3</TD><TD>N > 35</TD></TR>
<TR><TD>C4</TD><TD>complement 4</TD><TD>N > 10</TD></TR>
<TR><TD>RNP</TD><TD>anti-ribonuclear protein</TD><TD>N= -, +-</TD></TR>
<TR><TD>SM</TD><TD>anti-SM</TD><TD>N= -, +-</TD></TR>
<TR><TD>SCl70</TD><TD>anti-scl70</TD><TD>N= -, +-</TD></TR>
<TR><TD>SSA</TD><TD>anti-SSA</TD><TD>N= -, +-</TD></TR>
<TR><TD>SSB</TD><TD>anti-SSB</TD><TD>N= -, +-</TD></TR>
<TR><TD>CENTROMEA</TD><TD>anti-centromere</TD><TD>N= -, +-</TD></TR>
<TR><TD>DNA</TD><TD>anti-DNA</TD><TD>N < 8</TD></TR>
<TR><TD>DNA-II</TD><TD>anti-DNA</TD><TD>N < 8</TD></TR>
</TABLE>

<!--
<p>
All the temporal data are stored in tabular form as bellow:
<br>

ID,Date,GOT,GPT,LDH,ALP,TP  .............<br>
2110,860419,24,12,152,63,7.5 ............ <br>
2110,860430,25,12,162,76,7.9 ............ <br>
2110,860502,22,8,144,68,7 ............... <br>
...........................................<br>
</p>
-->

<p>&nbsp;</p>
<H4>This database was donated by dr. Katsuhiko Takabayashi and prepared by
prof. Shusaku Tsumoto</H4>
For more details on the data description, please use following contact 
addresses: 

<p></p>

<TABLE CELLSPACING=0 CELLPADDING=0 WIDTH=100%>


<TR><TD>Katsuhiko Takabayashi</TD><TD>Shusaku Tsumoto, M.D., Ph.D(Comp
Sci)</TD></TR> 
<!--  Associate Professor                     <br> -->
<TR><TD>
Email: <a href="mailto:takaba@ho.chiba-u.ac.jp">takaba@ho.chiba-u.ac.jp</a>
</TD><TD>
Email: <a href="mailto:tsumoto@computer.org"> tsumoto@computer.org</a>
</TD></TR>
<TR><TD>Department of Internal Medicine II</TD><TD>Department of Medical
Informatics</TD></TR>
<TR><TD>Chiba University Hospital</TD><TD>Shimane Medical University,             
  School of Medicine</TD></TR>
<TR><TD></TD><TD>89-1 Enya-cho, Izumo-city</TD></TR>
<TR><TD></TD><TD>Shimane 693-8501 Japan</TD></TR>
<TR><TD></TD><TD>TEL +81-853-20-2172</TD></TR>
<TR><TD></TD><TD>FAX +81-853-20-2170</TD></TR>
</TABLE>

</BODY>
</HTML>